FDA Clearance Tracker · P090012-S011
MELAFIND
Last checked: Nov 20, 2026Latest source record: Aug 18, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Aug 18, 2016
Approved
Time to decision
434 days
Received Jun 11, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P090012-S011
- Device name
- MELAFIND
- Applicant
- Strata Skin Sciences, Inc.
- Applicant location
- Horsham, PA
- Received
- Jun 11, 2015
- Decided
- Aug 18, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P090012
Device type
- Device class
- Class II
- Regulation
- 21 CFR 878.1820
- Specialty
- General & Plastic Surgery
FDA's approval statement
As written in FDA's record.
Approval for changing your calibration validation self-test method from the Field Phantom Imaging Self-Test to the Flap Shutter Self-Test.
Source documents
Other decisions for Strata Skin Sciences, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K193478 · Decided Jan 14, 2020 · 29 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.